Stock Ticker

  • Loading stock data...

Wall Street Highlight: The Dow Chemical (DOW), Allergan (AGN), Chesapeake Energy (CHK)

Boston, MA 09/24/2014 (wallstreetpr) – The Dow Chemical Company (NYSE:DOW) will be responsible for the reduction of greenhouse gas emissions at the upcoming 2016 Olympic Games in Brazil. The company was selected as the official partner for the environmental sustainability program during the games. The program seeks to lower the impact of the games on […]

Support Grows For Special Meeting Of Allergan, Inc. (NYSE:AGN) Shareholders

Boston, MA 09/12/2014 (wallstreetpr) – More investors in Allergan, Inc. (NYSE:AGN) continue to show their support for a special shareholder meeting, The Wall Street Journal stated in an article. The meeting is being sought by William Ackman’s Pershing Square Capital Management LP and Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The two are seeking to take over […]

Are Investors of Allergan, Inc. (NYSE:AGN) Taken For a Ride By Hedge Fund? Are Hedge Funds In Collusion Course On Allergan, Inc. (NYSE:AGN) Shares?

Boston, MA 08/15/2014 (wallstreetpr) – Are head fund companies made a big money out of Allergan, Inc. (NYSE:AGN)’s potential bid to be sold or a takeover target company? If so, are the investors taken for a ride? If reports are to be believed, the regulator, Securities Exchange Commission or the SEC, seemed to have seized […]

Morgan Stanley (NYSE:MS) Pitched Its Defense Services To Allergan

Boston, MA 06/19/2014 (wallstreetpr) – Morgan Stanley (NYSE:MS) is the advice-giver to the Canada based pharmaceutical company, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in its $53 billion bid for Allergan, Inc. (NYSE:AGN). Morgan Stanley, the global financial service firm initially attempted to get appointed by Allergan. According to Allergan, Morgan Stanley is the unwanted bidder in […]

Allergan, Inc. (NYSE:AGN) Loses Latisse Eyelash Ruling; Rejects Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Offer

Boston, MA 06/11/2014 (wallstreetpr) – Allergan, Inc. (NYSE:AGN), the Botox wrinkle therapy maker, lost a ruling in the appeals court which will cause generic versions of the company’s Latisse eyelash medicine enter the marketplace. Ruling Rejected Allergan, Inc. (NYSE:AGN) and Duke University owned two patents on its drug Latisse but as per the website posting, […]

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)

Boston, MA 06/02/2014 (wallstreetpr) – Valeant Pharmaceuticals Intl Inc (NYSE:VRX) increased its offer to acquire Allergan, Inc. (NYSE:AGN) for the second time in the week. Second Raise In A Week The Canada based drug maker said on Friday that it is agreeable to offer $72 and in addition a part of its stock for each […]